Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia.

A similar experimental design was employed to assess the impact of low‐sucrose (7% sucrose), or high‐sucrose diet (30%), in AML FLT3‐ITD‐bearing mice and found that survival appeared extended in the low‐sucrose + doxorubicin treatment group, but did not reach statistical significance ( p = 0.2) (Figure 1C ).

also in 111,027 other papers